DMTF1 Polyclonal Antibody

DMTF1 Polyclonal Antibody

Catalog Number:
A001509699RED
Mfr. No.:
RD267034A
Price:
$347
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Calculated MW: 84 kDa
          Observed MW: 85 kDa

          Please contact us at for specific academic pricing.

          Background

          This gene encodes a transcription factor that contains a cyclin D-binding domain, three central Myb-like repeats, and two flanking acidic transactivation domains at the N- and C-termini. The encoded protein is induced by the oncogenic Ras signaling pathway and functions as a tumor suppressor by activating the transcription of ARF and thus the ARF-p53 pathway to arrest cell growth or induce apoptosis. It also activates the transcription of aminopeptidase N and may play a role in hematopoietic cell differentiation. The transcriptional activity of this protein is regulated by binding of D-cyclins. This gene is hemizygously deleted in approximately 40% of human non-small-cell lung cancer and is a potential prognostic and gene-therapy target for non-small-cell lung cancer. Multiple transcript variants encoding different isoforms have been found for this gene.

      • Properties
        • Host
          rabbit
          Isotype
          IgG
          Reactivity
          human
          Immunogen
          Recombinant fusion protein of human DMTF1 (NP_066968.3).
          Purification
          Affinity purification
          Conjugate
          Unconjugated
          Formulation
          PBS with 0.02% sodium azide, 50% glycerol, pH7.3
          Storage
          Store at -20°C. Avoid freeze-thaw cycles.
          Concentration
          1 mg/mL
          Antigen
          DMTF1, DMP1, DMTF, MRUL, hDMP1 (Gene ID:9988; UniProt:Q9Y222)

          * For reference only.

      • Applications
        • Application
          WB
        • Application Dilutions
          WB 1:500-1:2000

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.